Study of Arimoclomol in Inclusion Body Myositis (IBM)
Basic Study Information
Purpose:
Funding Source - FDA OOPD. The purpose of this study is to evaluate the safety and
efficacy
of the study drug, Arimoclomol in IBM patients.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Elizabeth Luebbe
Study Contact Information
Study Coordinator: Liz Luebbe
Phone: 585-275-7867
Email: elizabeth_luebbe@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search